Shares of Pulmatrix, Inc. (NASDAQ:PULM – Get Free Report) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $1.87 and traded as high as $2.01. Pulmatrix shares last traded at $1.84, with a volume of 7,552 shares traded.
Analyst Ratings Changes
Separately, StockNews.com assumed coverage on Pulmatrix in a research report on Friday. They set a “hold” rating for the company.
Check Out Our Latest Analysis on Pulmatrix
Pulmatrix Stock Performance
Pulmatrix (NASDAQ:PULM – Get Free Report) last announced its quarterly earnings data on Thursday, March 28th. The biotechnology company reported ($0.57) earnings per share for the quarter. The company had revenue of $2.20 million for the quarter. Pulmatrix had a negative net margin of 193.49% and a negative return on equity of 63.94%.
About Pulmatrix
Pulmatrix, Inc, a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
See Also
- Five stocks we like better than Pulmatrix
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Roblox: The Bottom Just Fell Out of the Metaverse
- What is Forex and How Does it Work?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Pulmatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulmatrix and related companies with MarketBeat.com's FREE daily email newsletter.